Stonepine Capital Management, LLC Vericel Corp Transaction History

Stonepine Capital Management, LLC

  • $158 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 13, 2018
SELL
$3.65 - $5.98 $3.56 Million - $5.83 Million
-975,711 Closed
0 $0
Q3 2017

Nov 13, 2017
SELL
$3.0 - $6.0 $6.01 Million - $12 Million
-2,004,859 Reduced 67.26%
975,711 $5.85 Million
Q2 2017

Aug 14, 2017
BUY
N/A
2,980,570
2,980,570 $9.84 Million

Others Institutions Holding VCEL

# of Institutions
276
Shares Held
48.8M
Call Options Held
91.8K
Put Options Held
23.2K
View Full List

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.48B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track Stonepine Capital Management, LLC Portfolio

Follow Stonepine Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stonepine Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Stonepine Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email